Poland · Advertising framework
Promoting cosmetics and skincare through organic social media in Poland
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Substantiate the finished cosmetic product's claims
Legal requirement — paraphrased
Apply the six common criteria: legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. Match claims to the product information file. Ingredient studies do not establish the same effect for the finished formulation. Do not imply that an authority approved the cosmetic or its advertisement.
Present cosmetic functions accurately. Claims to treat disease require a classification review rather than simply a cosmetic disclaimer. Retouched results, before/after images and creator opinions must not misrepresent substantiated effects.
Sources: Regulation (EU) No 655/2013 — Common criteria for cosmetic claims; GIS — Applicable legislation for cosmetic products; Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Regulation 655/2013, Articles 1–2 and Annex
Channel rules
Make the overall message truthful and commercially identifiable
Legal requirement — paraphrased
Misleading claims, material omissions, hidden commercial intent and aggressive consumer marketing are prohibited. Assess visuals, comparisons, qualifications and the impression on vulnerable consumers. Do not falsely claim that a product cures illness.
Editorial control: retain substantiation before publication, remove fabricated urgency or authority badges, and check that qualifications do not contradict the headline. Paying to publish apparently independent advice must not conceal its commercial nature.
Sources: Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Articles 4–9; Article 7 hidden advertising and false cure claims
Check price reductions only after establishing that promotion is lawful
Legal requirement — paraphrased
Where an advertisement announces a reduction for a good or service, state the relevant lowest price from the preceding 30 days alongside the reduced price. For a shorter selling history, use the lowest price since sales began; special rules apply to rapidly perishable goods.
This consumer-information rule does not permit a discount or purchasing incentive prohibited by medicine or service rules. As an editorial check, make the total scope and extra charges clear.
Sources: UOKiK — Information about price reductions · Price Information Act Article 4 as explained by UOKiK
Keep reviews genuine and explain verification
Legal requirement — paraphrased
Do not publish, commission or distort false consumer recommendations. If making consumer reviews available, explain whether and how their origin is verified. Do not claim authentic-user verification without reasonable, proportionate checks.
Selecting a patient or customer story for advertising also requires checking the sector's claims and endorsement restrictions. A genuine testimonial can still contain an unlawful health claim.
Sources: UOKiK — False reviews? Stop!; Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845 · Unfair-practices Act Articles 6–7; UOKiK reviews guidance
Keep health data out of routine advertising workflows
Legal requirement — paraphrased
Establish a lawful processing basis, transparency and purpose limits. Health/genetic data also require a valid Article 9 condition; a treatment relationship does not automatically justify marketing reuse. Honour direct-marketing objections and withdrawable consent.
Editorial safeguard: keep symptoms, diagnoses, test results and appointment details out of advertising pixels, URLs, audience uploads and creator briefs unless a separately assessed lawful arrangement permits the processing.
Sources: Regulation (EU) 2016/679 — General Data Protection Regulation · Articles 5–7, 9, 13–14 and 21
Assess cookies, pixels and device access separately
Legal requirement — paraphrased
Prior information and consent are required for terminal storage/access unless a statutory exception applies, such as what is necessary for transmission or a service requested by the user. Ordinary advertising tracking should not be treated as necessary merely because it funds the website.
As an implementation control, test the consent mechanism before loading advertising tags and keep the privacy-processing assessment separate from the cookie-consent check.
Sources: Electronic Communications Law — Dz.U. 2024 item 1221 · Article 399
An unpaid post can still promote a regulated product or service
Editorial recommendation
Legal advertising definitions do not depend only on buying media. Review brand posts, employee posts issued on the brand's behalf, reposted testimonials and lives against the same sector rules. Do not disguise a commercial collaboration as spontaneous editorial content.
Use clear identification where commercial intent is not apparent. As an editorial control, brief moderators, review pinned comments and avoid public clinical replies disclosing patient information.
Sources: Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845; Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612; Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156; Patient Rights Act — consolidated text, Dz.U. 2024 item 581 · Commercial purpose and sector-specific rules
Include own-brand promotion in the disclosure review
Regulator guidance
UOKiK distinguishes paid collaborations, own-brand promotion and PR gifts. Promoting a creator’s own health brand is still a commercial context; assess the appropriate identification instead of treating the absence of an external sponsor as an exemption.
Record the relationship before choosing the label. Disclosure remains separate from the product’s eligibility and health-claim restrictions.
Sources: UOKiK — Influencer marketing recommendations and FAQ · UOKiK influencer marketing overview: collaboration, autopromotion and gifts
Campaign workflow
Keep one campaign evidence and approval record
Editorial recommendation
Recommended workflow: record the exact offer and legal classification, advertiser, selected channel and creative formats; list permitted claims and evidence; review the Polish execution and destination; record sign-off, publication and corrections.
Keep the source date with the rule. Recheck legislation flagged as changing, especially pharmacy advertising. Preserve statutory archive periods where they apply; this suggested general workflow does not create a universal retention period.
Sources: URPL — Advertising medical devices; Sejm official API — Pharmacy advertising amendment, process 3002 · Specific retention and legislative-watch sources; workflow is editorial
Pre-publication checklist
- Keep claim-specific evidence for the final formulation and ensure images show a supportable result.
- Review every tracking event and audience input for health-data disclosure.
- Record the category gate before reviewing the channel.
- Approve the final creative, disclosure, targeting and landing page together.
- Assign an owner for corrections, expiry of claims and legislative updates.
Scope and unresolved questions
- Product authorisations, intended users, approved documentation and final Polish creative must be checked for the actual offer. Veterinary products, controlled substances, vaccine exceptions and specialist product subtypes are not separately cleared by this category-level guide.
- Check the chosen platform/provider's current health-advertising, tracking and targeting policies for the actual account and country. This source pack covers legal/regulator rules, not every vendor policy.
Research scope, introduction and dates
For cosmetics and skincare in organic social posts in Poland, review what the finished product can support, rather than borrowing an ingredient's reputation. This guide brings claim substantiation, presentation of results and the boundary with medicinal claims into one review.
An unpaid brand post can still have a promotional purpose. Review captions, reposted customer experiences, employee contributions and live replies, including how a commercial message is identified when that purpose is not obvious.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
Resolve product and service restrictions before choosing a channel
Editorial overview
A platform label, newsletter consent, an advertising warning or a publisher's acceptance does not create permission to advertise. Apply the selected product/service gate first; if public promotion is prohibited, use this guide to identify the restriction and alternatives for specialist review.
This English guide describes Polish requirements. Required Polish warning text and locally understandable disclosure remain necessary where the law requires them.
Sources: Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612; Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156; Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620 · Product/service rules referenced in matching modules
Sources
- Pharmaceutical Law — consolidated text, Dz.U. 2026 item 612
Consolidation reflects 8 April 2026. Later amendments exist; pharmacy advertising must also be read with the CJEU judgment and the October 2026 legislative tracker in the pharmacy framework. This is a targeted advertising review, not an audit of the entire Act.
- Healthcare Activity Act — consolidated text, Dz.U. 2026 item 156
Public information must not have advertising characteristics. Information supplied at a patient's request under paragraph 2 is a different context.
- Medical Devices Act — consolidated working text based on Dz.U. 2024 item 1620
The inspected PDF is dated 19 November 2024. Advertising provisions were cross-checked against the current URPL advertising overview; recheck amendments before campaign sign-off.
- Regulation (EU) No 655/2013 — Common criteria for cosmetic claims
- GIS — Applicable legislation for cosmetic products
- Act on Counteracting Unfair Market Practices — consolidated text, Dz.U. 2023 item 845
- UOKiK — Information about price reductions
- UOKiK — False reviews? Stop!
The 30 July 2024 announcement also describes enforcement decisions; their subsequent appeal status is not asserted here.
- Regulation (EU) 2016/679 — General Data Protection Regulation
A healthcare-processing basis does not automatically authorise advertising use.
- Electronic Communications Law — Dz.U. 2024 item 1221
Original official text checked for these provisions. The Act has later amendments; this is a targeted review of the cited rules, not a complete consolidation audit.
- Patient Rights Act — consolidated text, Dz.U. 2024 item 581
Targeted review of these rights; not an audit of all subsequent amendments.
- UOKiK — Influencer marketing recommendations and FAQ
Recommendations explain the authority's approach; do not present every implementation recommendation as statutory wording.
- URPL — Advertising medical devices
- Sejm official API — Pharmacy advertising amendment, process 3002
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in Poland
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Poland.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
Marketing & sales advisory
Casbeg
Marketing and sales consulting for businesses in Poland: strategy, commercial processes, lead generation and CRM implementation.
View partner profileBusiness & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.